BioCryst Pharmaceuticals
BCRX
#4475
Rank
S$2.90 B
Marketcap
S$11.60
Share price
-3.84%
Change (1 day)
16.92%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of December 2025 : S$0.66 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are S$0.66 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31S$0.66 B-0.97%
2024-12-31S$0.66 B-2.36%
2023-12-31S$0.68 B-7.4%
2022-12-31S$0.73 B-7.27%
2021-12-31S$0.79 B79.56%
2020-12-31S$0.44 B87.38%
2019-12-31S$0.23 B17.8%
2018-12-31S$0.20 B-15.86%
2017-12-31S$0.23 B83.35%
2016-12-31S$0.13 B-24.87%
2015-12-31S$0.17 B-4.3%
2014-12-31S$0.18 B192.12%
2013-12-31S$61.91 M-11.86%
2012-12-31S$70.24 M-34.02%
2011-12-31S$0.10 B-24.48%
2010-12-31S$0.14 B-29.38%
2009-12-31S$0.19 B64.82%
2008-12-31S$0.12 B-41.02%
2007-12-31S$0.20 B95.56%
2006-12-31S$0.10 B-36.45%
2005-12-31S$0.16 B211.97%
2004-12-31S$52.96 M3.59%
2003-12-31S$51.13 M-28.65%
2002-12-31S$71.66 M-34.5%
2001-12-31S$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
S$75.90 B 11,379.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$105.84 B 15,908.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$4.30 B 551.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$3.79 B 473.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.51 B 128.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.74 B 13.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$10.74 M-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$36.2 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.87 B 184.15%๐Ÿ‡บ๐Ÿ‡ธ USA